Literature DB >> 25961495

A Brief Screening Tool to Assess the Risk of Contracting HIV Infection Among Active Injection Drug Users.

Dawn K Smith1, Yi Pan, Charles E Rose, Sherri L Pals, Shruti H Mehta, Gregory D Kirk, Jeffrey H Herbst.   

Abstract

OBJECTIVE: To incorporate preexposure prophylaxis and other biomedical or intensive behavioral interventions into the care of injection drug users (IDUs), health care providers need validated, rapid, risk screening tools for identifying persons at highest risk of incident HIV infection.
METHODS: To develop and validate a brief screening tool for assessing the risk of contracting HIV (ARCH), we included behavioral and HIV test data from 1904 initially HIV-uninfected men and women enrolled and followed in the AIDS Linked to the Intravenous Experience prospective cohort study between 1988 and 2008. Using logistic regression analyses with generalized estimating equations, we identified significant predictors of incident HIV infection, then rescaled and summed their regression coefficients to create a risk score.
RESULTS: The final logistic regression model included age, engagement in a methadone maintenance program, and a composite injection risk score obtained by counting the number of the following 5 behaviors reported during the past 6 months: injection of heroin, injection of cocaine, sharing a cooker, sharing needles, or visiting a shooting gallery. The area under the receiver operating characteristic curve was 0.720; possible scores on the index ranged from 0 to 100 and a score 46 or greater had a sensitivity of 86.2% and a specificity of 42.5%, appropriate for a screening tool. DISCUSSION: We developed an easy to administer 7-question screening tool with a cutoff that is predictive of incident HIV infection in a large prospective cohort of IDUs in Baltimore. The ARCH-IDUs screening tool can be used to prioritize persons who are injecting illicit drugs for consideration of preexposure prophylaxis and other intensive HIV prevention efforts.

Entities:  

Mesh:

Year:  2015        PMID: 25961495      PMCID: PMC4449303          DOI: 10.1097/ADM.0000000000000123

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  28 in total

1.  HIV infection and HIV-associated behaviors among injecting drug users - 20 cities, United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-03-02       Impact factor: 17.586

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

3.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

4.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

Review 5.  An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs.

Authors:  Nicholas Meader; Salaam Semaan; Marie Halton; Henna Bhatti; Melissa Chan; Alexis Llewellyn; Don C Des Jarlais
Journal:  AIDS Behav       Date:  2013-07

6.  Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.

Authors:  Steffanie A Strathdee; Jamila K Stockman
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

7.  Validity of self-reported substance use in men who have sex with men: comparisons with a general population sample.

Authors:  Michael Fendrich; Mary Ellen Mackesy-Amiti; Timothy P Johnson
Journal:  Ann Epidemiol       Date:  2008-08-09       Impact factor: 3.797

8.  Mortality risk among recent-onset injection drug users in five U.S. cities.

Authors:  David Vlahov; Cunlin Wang; Danielle Ompad; Crystal M Fuller; Wendy Caceres; Lawrence Ouellet; Peter Kerndt; Don C Des Jarlais; Richard S Garfein
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

9.  Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2012-11-09

10.  Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.

Authors:  Amy Lansky; Teresa Finlayson; Christopher Johnson; Deborah Holtzman; Cyprian Wejnert; Andrew Mitsch; Deborah Gust; Robert Chen; Yuko Mizuno; Nicole Crepaz
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

View more
  15 in total

1.  Misclassification of sexual health risks in a self-identified low risk cohort of men who have sex with men (MSM) enrolled in a community based PrEP program.

Authors:  Kellie Freeborn; Carmen Portillo; Cherie B Boyer; Glen Milo Santos
Journal:  AIDS Care       Date:  2019-05-25

2.  Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.

Authors:  Darrell H S Tan; Mark W Hull; Deborah Yoong; Cécile Tremblay; Patrick O'Byrne; Réjean Thomas; Julie Kille; Jean-Guy Baril; Joseph Cox; Pierre Giguere; Marianne Harris; Christine Hughes; Paul MacPherson; Shannon O'Donnell; Joss Reimer; Ameeta Singh; Lisa Barrett; Isaac Bogoch; Jody Jollimore; Gilles Lambert; Bertrand Lebouche; Gila Metz; Tim Rogers; Stephen Shafran
Journal:  CMAJ       Date:  2017-11-27       Impact factor: 8.262

3.  Using HIV Risk Prediction Tools to Identify Candidates for Pre-Exposure Prophylaxis: Perspectives from Patients and Primary Care Providers.

Authors:  Melissa B Gilkey; Julia L Marcus; Jacob M Garrell; Victoria E Powell; Kevin M Maloney; Douglas S Krakower
Journal:  AIDS Patient Care STDS       Date:  2019-06-17       Impact factor: 5.078

4.  HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers.

Authors:  Helen L Zhang; Sarah K Rhea; Christopher B Hurt; Victoria L Mobley; Heidi Swygard; Arlene C Seña; Mehri S McKellar
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

Review 5.  The role of healthcare providers in the roll out of preexposure prophylaxis.

Authors:  Douglas S Krakower; Kenneth H Mayer
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

6.  Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy.

Authors:  Carlos F Cáceres; Annick Borquez; Jeffrey D Klausner; Rachel Baggaley; Chris Beyrer
Journal:  J Int AIDS Soc       Date:  2016-10-18       Impact factor: 5.396

7.  Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care.

Authors:  Douglas Krakower; Kevin M Maloney; Victoria E Powell; Ken Levine; Chris Grasso; Kathy Melbourne; Julia L Marcus; Kenneth H Mayer
Journal:  J Int AIDS Soc       Date:  2019-02       Impact factor: 5.396

8.  A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study.

Authors:  Parya Saberi; Beth Berrean; Sean Thomas; Monica Gandhi; Hyman Scott
Journal:  JMIR Form Res       Date:  2018-01-16

9.  Performance and modification of EGCRISC among hepatitis C virus high-risk groups.

Authors:  E M El-Ghitany; Y M Alkassabany; A G Farghaly
Journal:  Epidemiol Infect       Date:  2020-02-14       Impact factor: 2.451

Review 10.  A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies.

Authors:  Aaron J Siegler; Kevin Steehler; Jessica M Sales; Douglas S Krakower
Journal:  Curr HIV/AIDS Rep       Date:  2020-12       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.